|
| |
Image Results
Loading...
Loading...
AMEVIVE Pages on BioPortfolio:
Results from other life science and pharmaceutical sites:
Amevive (alefacept)
10 Nov 2005 ... Biogen Idec and FDA notified healthcare professionals of revisions to CONTRAINDICATIONS section of the prescribing information for Amevive, ...
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyA...
|
Definition of Amevive - NCI Dictionary of Cancer Terms
Amevive is made by combining part of an antibody with a protein that blocks the growth some types of T cells. It is a type of fusion protein and a type of ...
http://www.nci.nih.gov/dictionary/?CdrID=572133...
|
AMEVIVE
The data presented in this briefing document demonstrate that AMEVIVE ...... IgG1 fusion protein, Amevive, Biogen, Cambridge, ...
http://www.fda.gov/ohrms/dockets/ac/02/briefing/3865B1_01_Bi...
|
Systemic Therapy for Psoriasis: Alefacept (Amevive®)
Alefacept (Amevive®): Psoriasis--learn about the latest therapies to provide better patient care.
http://www.medscape.com/viewarticle/575315_11...
|
News: Astellas to Acquire AMEVIVE(R) (alefacept); Acquisition of ...
3 Apr 2006 ... Astellas Pharma US, Inc. and Biogen Idec Inc. (NASDAQ: BIIB) today announced that an agreement for Astellas to purchase the worldwide rights ...
http://www.genengnews.com/news/bnitem.aspx?name=76395...
|
A case report of Hailey-Hailey disease treated with alefacept ...
Partial response of this patient's perineal disease was achieved with Amevive 15 mg weekly for 12 weeks, intramuscularly. To our knowledge, this case ...
http://www.ncbi.nlm.nih.gov/pubmed/17941942...
|
Biogen Idec, Inc. (Massachusetts) Promising AMEVIVE(R) Phase II ...
Patients treated with AMEVIVE also experienced less progression of disease, as measured by radiographic assessment, than placebo-treated patients after 24 ...
http://www.biospace.com/news_story.aspx?NewsEntityId=2762...
|
Alefacept (Amevive) for treatment of psoriasis.
Alefacept (Amevive) for treatment of psoriasis. [No authors listed]. Mesh Terms: Chills/chemically induced; Chronic Disease; Dose-Response Relationship, ...
http://www.ncbi.nlm.nih.gov/pubmed/12717339...
|
new letter
Biogen Idec is informing you of important new safety information regarding AMEVIVE®. (alefacept). This safety information includes a new CONTRAINDICATION ...
http://www.fda.gov/downloads/Safety/MedWatch/SafetyInformati...
|
Alefacept. Amevive, BG 9273, human LFA-3/Igg fusion protein, LFA 3 ...
Amevive, BG 9273, human LFA-3/Igg fusion protein, LFA 3, LFA 3 TIP LFA 3/CD2, LFA-3/Igg fusion protein, LFA3TIP, recombinant LFA-3/Igg1 human fusion protein ...
http://www.ncbi.nlm.nih.gov/pubmed/11881524...
|
|